Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

IntroductionClinical remission as a multicomponent treatment goal in severe asthma is being explored in clinical practice. This post hoc analysis used data from the REDES study to assess the proportion of patients with severe eosinophilic asthma achieving our multicomponent definitions of clinical r...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Ian Pavord, Frances Gardiner, Liam G. Heaney, Christian Domingo, Robert G. Price, Alison Pullan, John Oppenheimer, Guy Brusselle, Hiroyuki Nagase, Geoffrey Chupp, Emilio Pizzichini, David Bañas-Conejero, Peter Howarth
Định dạng:	Bài viết
Ngôn ngữ:	English
Được phát hành:	Frontiers Media S.A. 2023-04-01
Loạt:	Frontiers in Immunology
Những chủ đề:	severe asthma remission clinical outcomes real-world eosinophil biology mepolizumab
Truy cập trực tuyến:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150162/full

Những quyển sách tương tự

A Case of Eosinophilic Gastroenteritis Remission Achieved Steroid-Free With Mepolizumab
Bằng: Yuki Hirata, et al.
Được phát hành: (2022-01-01)

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
Bằng: Masanobu Ueno, et al.
Được phát hành: (2022-06-01)

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
Bằng: Mkorombindo T, et al.
Được phát hành: (2019-08-01)

Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with Mepolizumab
Bằng: Diego Bagnasco, et al.
Được phát hành: (2024-04-01)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
Bằng: Steven W. Yancey, et al.
Được phát hành: (2019-09-01)

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
Bằng: Haldar P
Được phát hành: (2017-06-01)

Mepolizumab-responsive recurrent eosinophilic eruption without peripheral eosinophilia
Bằng: Nina B. Curkovic, MD, et al.
Được phát hành: (2024-11-01)

The clinical question of mepolizumab in the long-term treatment of idiopathic chronic eosinophilic pneumonia; how long should we use mepolizumab?
Bằng: Masamitsu Hamakawa, et al.
Được phát hành: (2024-01-01)

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
Bằng: Masanobu Ueno, et al.
Được phát hành: (2021-03-01)

Effectiveness of mepolizumab for eosinophilic pneumonia following bronchial thermoplasty
Bằng: Ryota Otoshi, et al.
Được phát hành: (2020-03-01)

Clinical efficacy of mepolizumab in the treatment of severe eosinophilic asthma in children
Bằng: V. N. Drozdov, et al.
Được phát hành: (2020-11-01)

Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
Bằng: Giuseppe A. Ramirez, et al.
Được phát hành: (2022-12-01)

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
Bằng: Pelaia C, et al.
Được phát hành: (2017-10-01)

May mepolizumab used in asthma correct subfertility?
Bằng: Guzin Ozden, et al.
Được phát hành: (2021-01-01)

Allergic bronchopulmonary aspergillosis complicated by eosinophilic chronic rhinosinusitis successfully treated with mepolizumab
Bằng: Nobuhiro Matsumoto, et al.
Được phát hành: (2019-10-01)

Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India
Bằng: Venkata Nagarjuna Maturu, et al.
Được phát hành: (2021-08-01)

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
Bằng: Takanori Numata, et al.
Được phát hành: (2019-10-01)

Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma
Bằng: Jolita Palacionyte, et al.
Được phát hành: (2024-06-01)

Mepolizumab asthma treatment failure due to refractory airway eosinophilia, which responded to benralizumab
Bằng: Alistair Cook, et al.
Được phát hành: (2021-05-01)

Predictors of the enhanced response to mepolizumab treatment for severe eosinophilic asthma: A retrospective, long-term study
Bằng: Takanori Numata, et al.
Được phát hành: (2020-01-01)

Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study
Bằng: Kenneth R. Chapman, et al.
Được phát hành: (2024-02-01)

Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
Bằng: I. J. Pouliquen, et al.
Được phát hành: (2017-11-01)

Mepolizumab para el tratamiento de asma grave eosinofílica
Bằng: Armando Partida-Gaytán, et al.
Được phát hành: (2021-01-01)

When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case report
Bằng: M. Sabbe, et al.
Được phát hành: (2024-01-01)

Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan
Bằng: Takashi Yamane, et al.
Được phát hành: (2023-06-01)

Mepolizumab Therapy for Recalcitrant Eosinophilic Annular Erythema in an Adult: A Case Report and Review of Treatment Options
Bằng: Magdalena Żychowska, et al.
Được phát hành: (2020-06-01)

Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 3; peer review: 2 approved]
Bằng: Moetemri Zied, et al.
Được phát hành: (2023-09-01)

Real-world outcomes of mepolizumab treatment in severe eosinophilic asthma patients - retrospective cohort study in Slovakia
Bằng: Milos Jesenak, et al.
Được phát hành: (2023-09-01)

Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone
Bằng: Madeleine Lachance, MD, et al.
Được phát hành: (2022-04-01)

Combination effect of Mepolizumab and Endobronchial Watanabe Spigot (EWS) in drug‐induced eosinophilic pneumonia complicated by refractory pneumothorax
Bằng: Nana Ayame, et al.
Được phát hành: (2024-09-01)

Switching from omalizumab to mepolizumab therapy improved extra‐pulmonary abdominal and cutaneous vasculitis symptoms in a patient with eosinophilic granulomatosis with polyangiitis
Bằng: Yu‐Hsuan Chen, et al.
Được phát hành: (2022-01-01)

Role of mepolizumab in severe allergic asthma with vocal cord polyp
Bằng: Azmat Karim, et al.
Được phát hành: (2022-01-01)

Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series
Bằng: Carlo Lombardi, et al.
Được phát hành: (2024-07-01)

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
Bằng: Peter G. Gibson, et al.
Được phát hành: (2021-06-01)

Severe asthma remaining well‐controlled after mepolizumab discontinuation: A case report and literature review
Bằng: Takahiro Matsuyama, et al.
Được phát hành: (2023-06-01)

Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis
Bằng: Nami Masumoto, et al.
Được phát hành: (2023-05-01)

Severe eosinophilic bronchial asthma: new therapeutic options
Bằng: N. M. Nenasheva
Được phát hành: (2018-10-01)

Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance
Bằng: Marco Caminati, et al.
Được phát hành: (2023-09-01)

Gastrointestinal Involvement of Eosinophilic Granulomatosis with Polyangiitis with Histological Evidence of Treatment Response
Bằng: Mark Lai, et al.
Được phát hành: (2023-03-01)

Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma
Bằng: Manuel David Gil-Sierra, et al.
Được phát hành: (2019-11-01)